Amendment to Offer Letter and Appointment of Joseph Talamo as Senior Vice President & CFO of Caladrius Biosciences, Inc.

Summary

This letter amends Joseph Talamo's original offer letter and confirms his appointment as Senior Vice President and Chief Financial Officer of Caladrius Biosciences, Inc., effective October 6, 2015. He will report to the CEO, receive a $300,000 annual base salary, and be eligible for a bonus up to 30% of his salary. If terminated without cause or if his role is reduced due to an acquisition, he will receive six months' salary and benefits. All other employment terms remain unchanged.

EX-10.32 3 exh1032.htm EXHIBIT 10.32 Exhibit

Exhibit 10.32

October 6, 2015

Joseph Talamo

27 Brushy Ridge Road

New Canaan, CT 06840

Dear Joe,

This letter serves as an amendment to your offer letter dated June 28, 2011, and confirms your appointment to Senior Vice President & Chief Financial Officer of Caladrius Biosciences, Inc., (the “Company”), reporting to the Chief Executive Officer. This appointment is effective October 6, 2015.

In accordance with your appointment, your annual base salary shall be $300,000.00 and your target bonus shall be up to 30% of base salary. With your appointment, you shall serve as a member of the Company’s Executive Committee.

Should the Company terminate your employment without cause, or should you realize a reduction in duties, title, authority or responsibility that occurs by virtue of the Company being acquired, you will be entitled to receive severance in the amount of six (6) months’ base salary and benefits continuation for the severance period.

All other terms and conditions of your employment shall remain the same.

Congratulations on your well-deserved appointment! We look forward to your continued efforts and success.

Caladrius Biosciences, Inc.

/s/ David Schloss

David Schloss

Vice President, Human Resources

Acknowledged and Agreed:

106 Allen Road │ 4th Floor │ Basking Ridge, NJ│ 07920 │ Phone: (908) 842-0100

www.caladrius.com